Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 4/20 | 0.37 |
| ▸ | CYP1B1 | Q16678 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | MAPT | P10636 | 4/20 | 0.33 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19786644 | 0.89 | CYP1A1 (0.41) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL19786356 | 0.87 | MAPT (0.38) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL17071282 | 0.85 | HPGD (0.36) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL15126662 | 0.84 | CYP1A1 (0.36) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL15126695 | 0.84 | CYP1A1 (0.36) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL17071192 | 0.83 | HPGD (0.37) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL19786315 | 0.83 | CYP1A1 (0.37) | CYP1A1CYP1B1MAPTLMNACYP1A2 | |
| SCHEMBL19786641 | 0.83 | CYP1A1 (0.40) | CYP1A1CYP1B1CYP1A2 | |
| SCHEMBL23763293 | 0.83 | MEN1 (0.40) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 | |
| SCHEMBL19786535 | 0.83 | ATM (0.41) | CYP1A1CYP1B1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190300535-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-10-03 | — | — | US | disclosed |
| WO-2018012781-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2018-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190300535-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC DEVICE THEREOF | ORC3, OR51E2, ORAI2 | CYP1A1 3556/4885CYP1B1 4207/4885MEN1 698/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.